Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Papillomavirus Infections 2Hepatitis B 1

Interventions

Tenofovir 3entecavir 2tenofovir alafenamide 1human papillomavirus vaccine, L1 type 16, 18 1Standard of Care 1Practice Guidelines as Topic 1Lamivudine 1Engerix-B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hepatitis B × Engerix-B × Clear all
NCT00637195 2020-01-03

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

GlaxoSmithKline

Phase 3 Completed
152 enrolled 21 charts
Gynecologic

Uterine Cervical Neoplasms, Hepatitis B, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡